Education
About Us
Working with TipRanks
Follow Us
Materialise NV (MTLS)
NASDAQ:MTLS
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.02Last Year’s EPS
0.08Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 24, 2025
|% Change Since: 11.45%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive achievements, particularly in sustainability, medical segment growth, and cash position, alongside significant challenges, including a net loss, declines in software and manufacturing revenue, and decreased profitability metrics. The ongoing transition to a subscription-based model in the software segment also contributed to deferred revenue. While the company remains optimistic about stabilization in the second half of the year, current challenges weigh heavily on its performance.Company Guidance
During the first quarter of 2025, Materialise reported a revenue increase of more than 4%, reaching €66.4 million, despite challenging macroeconomic conditions. The Medical segment led with a nearly 19% growth, while the Software and Manufacturing segments saw a 6% revenue decline. The company reduced emissions by 32% in 2024 and aims for a 55% reduction by 2029. Adjusted EBIT stood at €0.6 million, with a net loss of €0.5 million, impacted by unfavorable exchange rate fluctuations. Materialise maintained a strong net cash position of €67.7 million, driven by positive free cash flow. For the full year, the company expects revenue between €270 million and €285 million and adjusted EBIT between €6 million and €10 million, anticipating stabilization in the second half of the year.Sustainability Progress
Materialise reduced emissions by 32% in 2024, reflecting a 3% reduction from 2023, and set a target to cut absolute emissions by 55% by 2029.
Revenue Growth
Despite challenging market conditions, Materialise grew its revenue by more than 4% in Q1 2025.
Medical Segment Performance
Materialise Medical increased revenue by almost 19% with continued strong uptake of personalized solutions.
Innovations in Software
Launch of Mimics Flow and new products like Magics 2025 release and next-generation build processors showed significant efficiency gains and technological advancements.
Aerospace Segment Growth
Sales in the aerospace segment grew by 23% in Q1 2025.
Strong Cash Position
Materialise increased its net cash position to €67.7 million by the end of Q1 2025, up by almost €7 million.
---
MTLS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MTLS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 24, 2025 | $4.63 | $5.29 | +14.25% |
| Feb 20, 2025 | $9.22 | $5.96 | -35.36% |
| Oct 24, 2024 | $5.09 | $6.02 | +18.27% |
| Jul 31, 2024 | $5.65 | $6.50 | +15.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Materialise NV (MTLS) report earnings?
Materialise NV (MTLS) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Materialise NV (MTLS) earnings time?
Materialise NV (MTLS) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MTLS EPS forecast?
MTLS EPS forecast for the fiscal quarter 2025 (Q2) is 0.02.
---